Nimbus bags $210 million to fuel computational drug discovery
The U.S. company Nimbus Therapeutics has raised $210 million in a financing round to fund the development of small molecule drugs powered by computational drug discovery.
Archives for September 8, 2023
Element Biosciences’ DNA sequencer hits “triple digit” quarterly sales growth
A benchtop DNA sequencer developed by the U.S. DNA sequencing company Element Biosciences, Inc., has seen sales grow by triple digits and has received more than 100 orders since its launch in March 2022.